PRINCETON - PDS Biotechnology Corporation (NASDAQ:PDSB) has confirmed plans to commence its VERSATILE-003 Phase 3 clinical trial for a promising cancer immunotherapy within the first quarter of 2025.

Heartland Dental, Aspen Dental and PDS Health are the three largest DSOs and MSOs in the dental industry. Here is how the three organizations stack up based on the number of practices in their network ...

Foundation made significant progress in 2024, expanding access to essential oral health care and reaching more patients and communities than ever before. From expanding care for patients with special ...

If you would like to have your scores and stats included in the daily recaps, send your scores and stats to Mansfield News ...

Blue Trust Inc. increased its stake in shares of Precision Drilling Co. (NYSE:PDS – Free Report) (TSE:PD) by 64.7% in the ...